Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Global Forecast 2023-2030
... 2022, at a CAGR of 7.56% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on ... Read More
-
Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2023-2030
... 13.04 billion by 2030 from USD 4.36 billion in 2022, at a CAGR of 14.67% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends ... Read More
-
Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2023-2030
... projected to reach USD 7.62 billion by 2030 from USD 3.88 billion in 2022, at a CAGR of 8.78% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, ... Read More
-
Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2023-2030
... reach USD 16.35 billion by 2030 from USD 9.23 billion in 2022, at a CAGR of 7.40% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2023-2030
... million by 2030 from USD 504.15 million in 2022, at a CAGR of 11.60% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in ... Read More
-
Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others), By End User (Biotechnology and Biopharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks), By Region and Competition
... during the forecast period, maintaining a robust Compound Annual Growth Rate (CAGR) of 7.55% through 2028. Diagnostic electrocardiogram (ECG) is a medical device employed to capture the electrical activity of the heart in waveforms, achieved ... Read More
-
Glycomics Market, 2028- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Enzymes(Glycosidases, Neuraminidases, Glycosyltransferases, Sialyltransferases, Others), Kits( Glycan Labeling Kits, Glycan Purification Kits, Glycan Release Kits, Others), Reagents( Glycoproteins, Monosaccharides, Oligosaccharides, Others), Instruments(Mass Spectrometers, HPLC, MALDI-TOF, Array Systems, Others)), By Application (Drug Discovery & Development, Diagnostics, Others), By End-use (Academic & Research Institutes, Hospitals & Clinics, Biopharmaceutical Companies, CROs), By Region, By Competition.
... in the forecast period, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.83% until 2028. The Global HIE Market is currently undergoing profound expansion and evolution, powered by the expanding digitization of healthcare systems, ... Read More
-
Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter Measurement, Blood Pressure Measurement, Cardiac Imaging, Thorough QT Studies), End User (Pharmaceutical & Biopharma, CROs), Region - Global Forecast to 2028
... services market is projected to reach USD 1,282 million by 2028 from USD 739 million in 2023, at a CAGR of 11.6% during the forecast period of 2023 to 2028. The growth of this market ... Read More
-
MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, Factor VIII ( Xyntha, Octanate, Kovaltry, Advate, Koate, Adynovate, Kogenate, Hemlibra, Elocta, Recombinate, Feiba, Immunate, Alphanate, Novoeight), Erythropoietin (Epoetin Alfa (Procrit, Epogen), Darbepoietin Alfa (Aranesp), Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt)
... Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt) MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, ... Read More
-
Global Biopharmaceuticals Market 2023-2030
... Testing, Compendial and Multi Compendial Laboratory Testing), and by Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Cardiovascular Diseases, Neurological Diseases and Other), Forecast Period (2023-2030) Global biopharmaceuticals market is anticipated to grow ... Read More
-
Rare Kidney Diseases Global Market Report 2023 Including: 1) By Target Indication: IgA Nephropathy; Lupus Nephritis; Focal Segmental Glomerular Sclerosis; Membranous Nephropathy; C3 Glomerulopathy 2) By Type of Molecule: Small Molecules; Biologics 3) By Route of administration: Oral; Intravenous; Subcutaneous Covering: Merck & Co. Inc.; Novartis AG; Sanofi S.A; AstraZeneca plc; GlaxoSmithKline plc
... Intravenous; SubcutaneousCovering: Merck & Co. Inc.; Novartis AG; Sanofi S.A; AstraZeneca plc; GlaxoSmithKline plc Rare Kidney Diseases Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Ankylosing Spondylitis Global Market Report 2023 Including: 1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery 2) By Molecule: Biologics; Biosimilar; Small Molecules 3) By Route of Administration: Parenteral; Oral 4) By Application: Juveniles; Adults 5) By End User: Hospitals; Clinics; Research Laboratoriesrs Covering: Pfizer Inc.; Johnson & Johnson Pvt. Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG
... of Administration: Parenteral; Oral4) By Application: Juveniles; Adults5) By End User: Hospitals; Clinics; Research LaboratoriesrsCovering: Pfizer Inc.; Johnson & Johnson Pvt. Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG Ankylosing Spondylitis Global Market Report ... Read More
-
Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2023 Including: 1) By Product Type: Prefilled Syringes; Vials; Cartridges 2) By Molecule Type: Large Molecules; Small Molecules 3) By End-User: Biopharmaceutical Companies; Pharmaceutical Companies Covering: AbbVie Inc.; Novartis AG; Thermo Fisher Scientific Inc.; Fresenius Kabi; Abbott Laboratories
... Fisher Scientific Inc.; Fresenius Kabi; Abbott Laboratories Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the ... Read More
-
Fill Finish Manufacturing Global Market Report 2023 Including: 1) By Product: Consumables; Instruments 2) By Modality: Recombinant Proteins; Monoclonal Antibodies; Vaccines; Cell Therapies; Viral Gene Therapies; Non-Viral Gene Therapies 3) By End-User: Contract Manufacturing Organizations; Biopharmaceutical Companiess Covering: Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc.
... Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc. Fill Finish Manufacturing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
Australia & South Korea Diabetic Foot Ulcer Market Size and Forecasts (2020 - 2030), Country Share, Trends, and Growth Opportunity Analysis Coverage By: Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country
... Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country The Australia & South Korea diabetic foot ulcer market is projected ... Read More
-
North America Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
... & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others) The North America bioprocess technology market is expected to grow from US$ 15,869.06 million in 2023 to US$ 33,696.06 million by 2028. It is estimated to ... Read More
-
Europe Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
... Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others) The Europe bioprocess technology market is expected to grow from US$ 12,290.88 million in 2023 to US$ 26,588.36 million by 2028. It is estimated to grow at ... Read More
-
Asia Pacific Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
... & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others) The Asia Pacific bioprocess technology market is expected to grow from US$ 4,608.64 million in 2023 to US$ 11,000.75 million by 2028. It is estimated to ... Read More
-
South & Central America Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
... User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others) The South & Central America bioprocess technology market is expected to grow from US$ 1,531.47 million in 2023 to US$ 3,361.13 million by 2028. ... Read More
-
Middle East & Africa Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
... User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others) The Middle East & Africa bioprocess technology market is expected to grow from US$ 1,233.00 million in 2023 to US$ 2,443.75 million by 2028. ... Read More
-
Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecasts to 2028
... manufacturing market is estimated to reach USD 24.8 billion by 2028 from USD 16.6 billion in 2023, at a CAGR of 8.3% during the forecast period of 2023 to 2028. The growth of this market ... Read More
-
Ulcerative Colitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028. Ulcerative colitis (UC) refers to a chronic inflammatory bowel disease (IBD) that causes irritation, inflammation, and ulcers (sores) in the ... Read More
-
Microcarrier Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... is a help matrix, which lets in the increase of adherent cells in bioreactors. In the large-scale business production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cellular populations. As ... Read More
-
Biologics Outsourcing Market Size - By Product (Antibodies, Recombinant Proteins, Vaccines), Service (Cell & Process Development, Analytical Testing), Source (Mammalian, Microorganism), Application, End-user, Global Forecast, 2023 - 2032
... expand at 14.1% CAGR from 2023-2032 driven by the increasing focus on R&D collaborations between biopharmaceutical companies and outsourcing partners. The rising complexities of biological drug development and production along with collaborative partnerships are enabling ... Read More
-
Biopharmaceutical CMO Market Forecasts to 2030 – Global Analysis By Product (Biologics, Biosimilars and Other Products), Source, Service and By Geography
... in 2023 and is expected to reach $39.41 billion by 2030 growing at a CAGR of 14.6% during the forecast period. A biopharmaceutical CMO, often referred to as a contract manufacturing organization, is a business ... Read More
Research Assistance
